Search the Newsreel

Will AVLAYAH’s Launch And Cash Windfall Reshape Denali Therapeutics' (DNLI) Investment Narrative

ZENA Stock In Spotlight After Latest Acquisition Marks Major Push Into Asia-Pacific – Here’s How This Will Impact Its Customer Base

Ikarian Capital (TENX) discloses 2.9% beneficial stake in Tenax Therapeutics common stock

Ikarian Capital, LLC and Neil Shahrestani have reported a 2.9% beneficial ownership stake in Tenax Therapeutics, Inc. (TENX) common stock, totaling 1,080,700 shares. This includes 373,100 shares acquirable within 60 days via options, based on 37,423,917 shares outstanding as of July 28, 2026. The …

Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings?

Covenant Logistics (CVLG): Buy, Sell, or Hold Post Q2 Earnings? Since August 2021, the S&P 500 has delivered a total return of 73.7%. But one standout stock has more than doubled the market - over the past five years, Covenant Logistics has surged 201% …

Covenant Logistics Group (CVLG) Holds Steady with Modest Gains, Trading Within Established Range - Breakout Stock Alerts

Here’s How Much You Would Have Made Owning Fastenal Stock In The Last 10 Years

Fastenal Company (NASDAQ: FAST) has shown significant outperformance over the last decade, with an average annual return of 16.61%, surpassing the market by 3.11%. An initial investment of $1000 in FAST stock 10 years ago would now be worth $4,679.66. This demonstrates the substantial …

Tenax Therapeutics Stock Price Forecast. Should You Buy TENX?

Ciena Corp (CIEN) Stock Down 3.2% but Still Overvalued -- GF Sco

Ciena Corp (CIEN) shares recently dropped 3.2% to $428.77, yet GuruFocus assesses the stock as significantly overvalued with a GF Value™ of $99.71. The company has a GF Score™ of 72/100, indicating above-average performance with strong financial strength and growth, but a poor valuation …

Ciena (NYSE:CIEN) Stock Price Down 3.1% - Should You Sell?

Ciena (NYSE:CIEN) shares dropped 3.1% during mid-day trading, despite strong analyst sentiment with a "Moderate Buy" consensus and an average price target of $530.56. The company recently exceeded quarterly earnings expectations, reporting EPS of $1.64 against an expected $1.46 and revenue of $1.57 billion, …

Form 8K Covenant Logistics Group Inc For: 14 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Covenant Logistics Group Inc. on August 14th. The brief piece includes the stock symbol CVLG and mentions a slight positive change in its value. The content primarily serves as a notification of …

Ciena (CIEN) insider files to sell 2,500 shares after recent 10b5-1 sales

An insider at Ciena Corporation (CIEN), David Rothenstein, has filed a Form 144 to sell 2,500 shares of common stock, valued at $1,106,975.00. These shares are related to Restricted Stock Units from 2021. The filing also notes previous 10b5-1 plan sales of 2,500 shares …

Ciena (CIEN) insider Marc Graff files Form 144 to sell 4,995 shares

Ciena Corporation insider Marc Graff has filed a Form 144 notice to sell 4,995 shares of common stock, valued at $2,211,736.05. These shares are related to Restricted Stock Units acquired on August 1, 2026. The filing also details previous Rule 10b5-1 sales by Graff …

Shenandoah Telecom (SHEN): Southeastern, Longleaf update 4.7% ownership stake

Southeastern Asset Management, Longleaf Partners Small-Cap Fund, and O. Mason Hawkins have filed an updated Schedule 13G/A, reporting their beneficial ownership in Shenandoah Telecommunications Company (SHEN). The filing indicates that Southeastern beneficially owns 2,616,797 shares and Longleaf owns 2,612,640 shares, together representing a 4.7% …

Jena Acquisition Corporation (NYSE: JENA) earns $2.98M on trust income but faces deadlines

Van Eck Associates (SKE) reports 9,017,001 Skeena Resources shares, a 7.2% stake

Van Eck Associates Corporation has filed an amended beneficial ownership report for Skeena Resources Ltd., disclosing a 7.2% stake in the company. Van Eck beneficially owns 9,017,001 Skeena Resources Ord Shs, holding sole voting and dispositive power over all these shares. The filing indicates …

Skeena Resources (SKE) Q2 2026 Results Highlight Cash Burn, P/S Valuation Challenges

Genasys Inc. remains a Hold due to unprofitable core business outside Puerto Rico project.

Genasys Inc. is currently rated as a Hold because its core business is unprofitable, despite a temporary boost from a Puerto Rico project. This project is now paused due to issues with receivables and liquidity, exposing the company's weak financial fundamentals. Outside of Puerto …

Jena Acquisition Corporation II Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Renatus Tactical (RTAC) posts Q2 update with $252M in trust and going concern risk

Renatus Tactical Acquisition Corp I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Genasys Ex-Puerto Rico Quarter Shows How Dire Its Situation Is (NASDAQ:GNSS)

Genasys Inc. (GNSS) is rated a Hold due to its core business being deeply unprofitable outside of the Puerto Rico project. While recent profitability stemmed from this project, liquidity issues have paused it, revealing weak fundamentals. The company faces a strained balance sheet, costly …

Zenas BioPharma (ZBIO) Is Down 9.2% After Wider Losses And Leadership Changes - What's Changed

Zenas BioPharma reported widening losses in Q2 2026, with revenue dropping significantly year-over-year and net loss reaching US$111,460,000. These financial results were accompanied by leadership changes, including the CFO transitioning to a Strategic Advisor role and a new board appointment. The company's investment narrative …

Shenandoah Telecommunications Co (SH9) Q1 2024 Earnings Report - Results, Call & Slides

Shenandoah Telecommunications Co (SH9) reported its Q1 2024 earnings, missing both EPS and revenue expectations. The company posted an actual EPS of -€0.07 against a consensus of -€0.02 and actual revenue of €60.15M compared to an expected €62.12M, representing a 3.40% year-over-year decrease in …

Denali Therapeutics CEO Ryan J. Watts Donates 32,220 Shares to Donor Advised Fund

Denali Therapeutics Inc. CEO, Ryan J. Watts, donated 32,220 shares of common stock to a donor-advised fund on August 12, 2026, as disclosed in an SEC Form 4 filing. This charitable gift, valued at $0, was reported on August 14, 2026. Following the donation, …

Will Ciena's Rising Backlog Improve Revenue Visibility Into 2027?

Ciena Corporation is experiencing strong demand and a growing backlog, which is expected to provide increased revenue visibility into fiscal 2027. The company's backlog surged to $7.7 billion in Q2 fiscal 2026, with a significant portion anticipated to convert into revenue within the next …

Renatus Tactical Acquisition Corp I (RTAC) investor reports 6.87% Class A ownership

Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. have filed an amended Schedule 13G disclosure for Renatus Tactical Acquisition Corp I (RTAC), reporting beneficial ownership of 1,657,888 Class A shares, which represents 6.87% of the class. This filing indicates shared voting and dispositive …

Compañía de Minas Buenaventura y su nueva prioridad en pleno rally de metales

Compañía de Minas Buenaventura is shifting its focus to exploration over acquisitions due to record high metal prices, increasing its exploration budget by 30%. The company plans to maintain its CAPEX between US$385 million and US$415 million but will accelerate prospection and reevaluate mature …

Zenas BioPharma's (ZBIO) Buy Rating Reaffirmed at Guggenheim

Guggenheim reaffirmed its "buy" rating for Zenas BioPharma (ZBIO) with a $55 price target, despite the company reporting weaker-than-expected quarterly results, including an EPS loss of $1.77 and revenue of $1 million. Analyst sentiment for ZBIO remains generally positive with a "Moderate Buy" consensus …

Renasant Corp. (RNST) Q4 2025 Earnings Report - Results, Call & Slides

Renasant Corp. (RNST) released its Q4 2025 earnings, reporting an actual EPS of $0.83, surpassing the consensus of $0.78, and actual revenue of $394.53 million, significantly beating the expected $275.85 million. This represents a substantial year-over-year revenue growth of 52.78%. The company's earnings call …

Zenas BioPharma's (ZBIO) Outperform Rating Reiterated at Wedbush

Wedbush reiterated its "outperform" rating on Zenas BioPharma (NASDAQ:ZBIO) with a $45 price target, indicating a potential 54.11% upside. Despite this positive analyst sentiment, the company reported a significant miss on its quarterly earnings and revenue estimates. Other analysts have also adjusted their ratings, …

RTW Investments discloses 9.99% Tenax Therapeutics (TENX) position with 2.87M shares

RTW Investments and Roderick Wong, M.D. have reported a beneficial ownership of 9.99% in Tenax Therapeutics, Inc., amounting to 2,866,654 shares. This stake includes shares issuable upon the exercise of warrants, subject to a 9.99% beneficial ownership limitation. The filing, a SCHEDULE 13G/A, details …

TENB|Tenable Holdings Inc|Price:40.065|Chg%:+3.065

Henan Jinyuan Sets Board Meeting to Review Interim Results and Consider Dividend

Henan Jinma Energy Sets Board Meeting to Approve 2026 Interim Results and Consider Dividend

China Renaissance Sets Board Meeting to Approve Interim 2026 Results

Tema ETFs LLC Sells 48,552 Shares of Fastenal Company $FAST

Tema ETFs LLC significantly reduced its stake in Fastenal Company (NASDAQ:FAST) by 68.2% in the second quarter, selling 48,552 shares and retaining 22,629 shares valued at $1.09 million. Despite mixed analyst ratings, Fastenal reported strong quarterly revenue of $2.39 billion, a 14.7% year-over-year increase, …